Angiotensin-Converting Enzyme-2 (ACE-2) with Interferon-Induced Transmembrane Protein-3 (IFITM-3) Genetic Variants and Interleukin-6 as Severity and Risk Predictors among COVID-19 Egyptian Population
Table 2
Comparison between the studied populations regarding clinical presentation and complications.
Group I (n = 380)
Group II (n = 520)
No.
%
No.
%
Clinical presentation
Fever
288
75.8
324
62.3
<0.001
Cough
274
72.1
240
46.2
<0.001
Dyspnea
252
66.3
289
55.6
0.001
Headache
46
12.1
78
15.0
0.213
Chest pain
38
10.0
51
9.8
0.924
Vomiting or nausea
38
10.0
51
9.8
0.924
Diarrhea
38
10.0
51
9.8
0.924
Myalgia or arthralgia
90
23.7
119
22.9
0.779
Disturbed conscious level
60
15.8
91
17.5
0.498
Complications
ARDS
200
52.6
181
34.8
<0.001
AKI
110
28.9
142
27.3
0.588
Sepsis
90
23.7
13
2.5
<0.001
Recurrence
20
5.3
53
10.2
0.007
: value for comparing between the two studied groups. Statistically significant at . ARDS: acute respiratory distress syndrome and AKI: acute kidney injury.
